Metabolic Regulation Peptides Bioactive Toxin-Derived Peptides Tumor-Associated Antigen Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Neurodegenerative Disease Research Peptides Melanogenesis Modulation Anti-Aging & Skin Remodeling Gastrin, GRP & Bombesin Peptides Somatostatin Analogs DPPIV/CD26 Peptides Kinase Activity Modulators Caspase Substrates & Inhibitors Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Calcitonin & CGRP Family Peptides Incretin & Metabolic Peptides Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Peptide Coupling Reagents & Additives Specialty Peptide Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Neuromodulatory and Neuroactive Peptides Neurotransmitters/Neuropeptides [D-Pro4,D-Trp7,9,10]-Substance P (4-11) | Tachykinin Antagonist

DESCRIPTION

[D-Pro4,D-Trp7,9,10]-Substance P (4-11) is a classical octapeptide Substance P analog containing D-Pro at position 4 and D-Trp at positions 7, 9 and 10.

The extensive stereochemical and aromatic substitutions convert the C-terminal Substance P fragment into a peptide tachykinin antagonist that has been studied in smooth-muscle, signaling and central nervous system models.

Product Information

Product Name[D-Pro4,D-Trp7,9,10]-Substance P (4-11)
Catalog No.AS2361
CAS No.86917-57-9
SequenceD-Pro-Gln-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2
Peptide Length8 residues
Molecular FormulaC62H74N14O10S
Molecular WeightApproximately 1207.4 Da
Key ModificationsD-Pro4; D-Trp7; D-Trp9; D-Trp10
C-TerminusMet-NH2
Pharmacological ProfilePeptide tachykinin antagonist

A Classical D-Amino-Acid Substance P Antagonist

The analog belongs to an early generation of peptide tachykinin antagonists developed by replacing selected residues within the SP(4-11) pharmacophore with D-amino acids and bulky aromatic side chains.

D-Trp10 replaces the native Leu10 residue, substantially increasing aromatic character in the C-terminal region.

Tissue-Dependent Antagonist Pharmacology

The peptide has inhibited Substance P and other tachykinin responses in multiple smooth-muscle preparations and has also been evaluated in central nervous system models.

Classical studies showed that its apparent antagonist potency varies between tissues. This observation helped establish that early functional preparations could contain different tachykinin receptor populations.

We recommend treating this compound as a classical pharmacological tool rather than assigning a single modern receptor-subtype affinity to all experimental systems.

Research Applications

[D-Pro4,D-Trp7,9,10]-Substance P (4-11) can support tachykinin antagonist studies, smooth-muscle pharmacology, inositol phosphate signaling experiments, CNS Substance P research and peptide SAR.

Frequently Asked Questions

Is this an NK1-selective antagonist?

It is a classical Substance P/tachykinin antagonist, but historical studies show substantial tissue dependence. It should not automatically be treated as equivalent to a modern highly selective NK1 small-molecule antagonist.

What is replaced at position 10?

Native Leu10 is replaced by D-Trp.

Is Met11 retained?

Yes. The C-terminal Met-NH2 remains present.

Research Use Only.

[D-Pro4,D-Trp7,9,10]-Substance P (4-11) | Tachykinin Antagonist

Catalog No: AS2361
Cas No: 86917-57-9

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit